[1] 胡盛寿. 中国心血管病报告[M].北京:中国大百科全书出版社,2019:151-159. [2] Cleland JGF, Lyon AR, McDonagh T, et al. The year in cardiology: heart failure[J]. Eur Heart J,2020,41(12):1232-1248. [3] Task Force Members, Montalescot G, Sechtem U,et al.2013 ESC guidelines on the management of stable coronary artery disease: The task force on the management of stable coronary artery disease of the European society of cardiology[J].Eur Heart J,2013,34(38):2949-3003. [4] Roffi M, Patrono C, Collet JP, et al.2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC)[J].Eur Heart J,2016,37(3):267-315. [5] O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American college of cardiology foundation/American heart association task force on practice guidelines[J].Circulation,2013,127(4):362-425. [6] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122. [7] Cheitlin MD, Armstrong WF, Aurigemma GP, et al.ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article. A report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography)[J].J Am Soc Echocardiogr,2003,16(10):1091-110. [8] Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study[J].J Am Coll Cardiol,2008, 51(3):264-270. [9] Li J, Luo YY, Xu YW, et al.Risk factors of peripheral arterial disease and relationship between low ankle-brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with type 2 diabetes[J].Circ J,2007, 71(3):377-381. [10] Horvath K, Koch K, Jeitler K, et al.Effects of treatment in women with gestational diabetes mellitus: Systematic review and meta-analysis[J].BMJ,2010, 340:1395. [11] Parissis JT, Mantziari L, Kaldoglou N, et al.Gender-related differences in patients with acute heart failure: Management and predictors of in-hospital mortality[J].Int J Cardiol,2013,168(1):185-189. [12] Kim HL, Kim MA, Park KT, et al.Gender difference in the impact of coexisting diabetes mellitus on long-term clinical outcome in people with heart failure: A report from the Korean Heart Failure Registry[J]. Diabet Med, 2019, 36(10):1312-1318. [13] 刘敏,常琰,安乐,等.西安市社区≥50岁人群心力衰竭患病现状和影响因素调查[J].华南预防医学,2021,47(9):1127-1130. [14] Tharu BP, Tsokos CP.A statistical study of serum cholesterol level by gender and race[J].J Res Health Sci,2017,17(3):e00386. [15] Pan L, Yang Z, Wu Y, et al.The prevalence, awareness, treatment and control of dyslipidemia among adults in China[J].Atherosclerosis,2016,248:2-9. [16] Izumida T, Nakamura Y, Sato Y, et al.Association among age, gender, menopausal status and small dense low-density lipoprotein cholesterol: A cross-sectional study[J].BMJ Open,2021,11(2):041613. [17] McDonagh TA, Metra M, Adamo M, et al.2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Eur Heart J,2021,42(36):3599-3726. [18] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789. [19] Bachmann KN, Huang S, Lee H, et al.Effect of testosterone on natriuretic peptide levels[J].J Am Coll Cardiol,2019,73(11):1288-1296. [20] Cediel G, Codina P, Spitaleri G, et al.Gender-related differences in heart failure biomarkers[J].Front Cardiovasc Med,2021,7:617705. [21] Hsich EM, Grau-Sepulveda MV, Hernandez AF, et al.Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with in hospital outcomes: Findings from the get with the guideline-heart failure registry[J].Am Heart J,2013,166(6):1063-1071. [22] Wang TJ, Larson MG, Levy D, et al.Plasma natriuretic peptide levels and the risk of cardiovascular events and death[J].N Engl J Med,2004,350:655-663. |